| Bioactivity | SOICR-IN-1 (compound 32) is a store-overload induced calcium release (SOICR) inhibitor with an IC50 value of 14.6 μM. SOICR-IN-1 can be used for the research of cardiac arrhythmias[1]. | ||||||||||||
| Name | SOICR-IN-1 | ||||||||||||
| CAS | 1479049-35-8 | ||||||||||||
| Formula | C27H28N2O5 | ||||||||||||
| Molar Mass | 460.52 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Smith CD, et al. Novel carvedilol analogues that suppress store-overload-induced Ca2+ release. J Med Chem. 2013 Nov 14;56(21):8626-55. |
SOICR-IN-1
CAS: 1479049-35-8 F: C27H28N2O5 W: 460.52
SOICR-IN-1 (compound 32) is a store-overload induced calcium release (SOICR) inhibitor with an IC50 value of 14.6 μM. S
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.